South Korea · Delayed Price · Currency is KRW Bio Port Korea Statistics
Total Valuation
Bio Port Korea has a market cap or net worth of KRW 22.09 billion. The enterprise value is 19.77 billion.
| Market Cap | 22.09B |
| Enterprise Value | 19.77B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bio Port Korea has 4.61 million shares outstanding. The number of shares has increased by 13.55% in one year.
| Current Share Class | 4.61M |
| Shares Outstanding | 4.61M |
| Shares Change (YoY) | +13.55% |
| Shares Change (QoQ) | +1.26% |
| Owned by Insiders (%) | 48.37% |
| Owned by Institutions (%) | 0.46% |
| Float | 1.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.29 |
| PB Ratio | 0.54 |
| P/TBV Ratio | 0.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.83, with an EV/FCF ratio of -4.10.
| EV / Earnings | -27.08 |
| EV / Sales | 0.26 |
| EV / EBITDA | 4.83 |
| EV / EBIT | 12.24 |
| EV / FCF | -4.10 |
Financial Position
The company has a current ratio of 2.26, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.26 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | 2.74 |
| Debt / FCF | -2.33 |
| Interest Coverage | 5.68 |
Financial Efficiency
Return on equity (ROE) is -2.09% and return on invested capital (ROIC) is 4.49%.
| Return on Equity (ROE) | -2.09% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 4.49% |
| Return on Capital Employed (ROCE) | 3.68% |
| Weighted Average Cost of Capital (WACC) | 3.43% |
| Revenue Per Employee | 704.64M |
| Profits Per Employee | -6.82M |
| Employee Count | 107 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -274.25M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.96% in the last 52 weeks. The beta is -0.02, so Bio Port Korea's price volatility has been lower than the market average.
| Beta (5Y) | -0.02 |
| 52-Week Price Change | -63.96% |
| 50-Day Moving Average | 5,746.00 |
| 200-Day Moving Average | 8,498.95 |
| Relative Strength Index (RSI) | 37.17 |
| Average Volume (20 Days) | 38,464 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bio Port Korea had revenue of KRW 75.40 billion and -730.25 million in losses. Loss per share was -165.84.
| Revenue | 75.40B |
| Gross Profit | 18.97B |
| Operating Income | 1.62B |
| Pretax Income | -1.00B |
| Net Income | -730.25M |
| EBITDA | 4.09B |
| EBIT | 1.62B |
| Loss Per Share | -165.84 |
Balance Sheet
The company has 13.55 billion in cash and 11.23 billion in debt, with a net cash position of 2.31 billion or 501.76 per share.
| Cash & Cash Equivalents | 13.55B |
| Total Debt | 11.23B |
| Net Cash | 2.31B |
| Net Cash Per Share | 501.76 |
| Equity (Book Value) | 41.18B |
| Book Value Per Share | 8,929.44 |
| Working Capital | 20.76B |
Cash Flow
In the last 12 months, operating cash flow was -382.27 million and capital expenditures -4.45 billion, giving a free cash flow of -4.83 billion.
| Operating Cash Flow | -382.27M |
| Capital Expenditures | -4.45B |
| Depreciation & Amortization | 2.48B |
| Net Borrowing | -4.15B |
| Free Cash Flow | -4.83B |
| FCF Per Share | -1,047.15 |
Margins
Gross margin is 25.16%, with operating and profit margins of 2.14% and -0.97%.
| Gross Margin | 25.16% |
| Operating Margin | 2.14% |
| Pretax Margin | -1.33% |
| Profit Margin | -0.97% |
| EBITDA Margin | 5.43% |
| EBIT Margin | 2.14% |
| FCF Margin | n/a |
Dividends & Yields
Bio Port Korea does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -13.55% |
| Shareholder Yield | -13.55% |
| Earnings Yield | -3.31% |
| FCF Yield | -21.86% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 16, 2025. It was a reverse split with a ratio of 0.1486215.
| Last Split Date | May 16, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1486215 |
Scores
Bio Port Korea has an Altman Z-Score of 3.59 and a Piotroski F-Score of 1.
| Altman Z-Score | 3.59 |
| Piotroski F-Score | 1 |